tiprankstipranks
Sino-Life Group Limited (HK:8296)
:8296
Hong Kong Market
Want to see HK:8296 full AI Analyst Report?

Sino-Life Group Limited (8296) Price & Analysis

0 Followers

8296 Stock Chart & Stats

HK$0.40
HK$0.02(3.75%)
At close: 4:00 PM EST
HK$0.40
HK$0.02(3.75%)

Bulls Say, Bears Say

Bulls Say
Improved Leverage / Stable Balance SheetThe balance sheet shows a materially improved debt-to-equity ratio versus 2020 and a sizable equity base. That stronger leverage profile provides durable financial flexibility over months, reducing near-term refinancing risk and giving runway to address operating weaknesses if cash burn is managed.
Relatively Healthy Gross MarginsGross margins in the low-40% to low-50% range indicate the core product economics retain meaningful mark-up. Persistently healthy gross margin is a structural advantage that can support a return to operating profitability if fixed costs and SG&A are tightened or revenue stabilizes, sustaining margins long-term.
Evidence The Business Can Be ProfitableThe company produced positive EBIT in 2020 and 2022, showing the underlying operations can reach profitability under the right conditions. This historical proof of concept suggests operational levers exist to restore profits, offering a realistic recovery pathway versus a structurally unprofitable model.
Bears Say
Persistent Net LossesSustained net losses across reporting years indicate the firm is structurally unprofitable at present. Continued losses erode shareholders' equity over time, limit reinvestment capacity, and increase dependence on external financing or asset sales, undermining long-term financial resilience if not reversed.
Negative Operating And Free Cash FlowThree years of negative operating and free cash flow, with a sharp deterioration in 2025, show the company lacks self-funding capacity. Persistent cash burn elevates liquidity and funding risk, forcing reliance on the balance sheet or capital markets and constraining investment in growth or margin recovery over months.
Recent Material Revenue DeclineA roughly 18% revenue decline in 2025 (and negative multi-year revenue growth) signals weakening demand or lost market share. Top-line deterioration undermines operating leverage and makes margin recovery harder, limiting the firm's ability to capitalize on its gross-margin strength without structural revenue stabilization.

8296 FAQ

What was Sino-Life Group Limited’s price range in the past 12 months?
Sino-Life Group Limited lowest stock price was HK$0.10 and its highest was HK$0.53 in the past 12 months.
    What is Sino-Life Group Limited’s market cap?
    Sino-Life Group Limited’s market cap is HK$27.40M.
      When is Sino-Life Group Limited’s upcoming earnings report date?
      Sino-Life Group Limited’s upcoming earnings report date is Aug 07, 2026 which is in 59 days.
        How were Sino-Life Group Limited’s earnings last quarter?
        Sino-Life Group Limited released its earnings results on Mar 31, 2026. The company reported -HK$0.025 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.025.
          Is Sino-Life Group Limited overvalued?
          According to Wall Street analysts Sino-Life Group Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Sino-Life Group Limited pay dividends?
            Sino-Life Group Limited does not currently pay dividends.
            What is Sino-Life Group Limited’s EPS estimate?
            Sino-Life Group Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Sino-Life Group Limited have?
            Sino-Life Group Limited has 94,500,000 shares outstanding.
              What happened to Sino-Life Group Limited’s price movement after its last earnings report?
              Sino-Life Group Limited reported an EPS of -HK$0.025 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Sino-Life Group Limited?
                Currently, no hedge funds are holding shares in HK:8296
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Sino-Life Group Limited

                  Sino-Life Group Limited operates as an investment holding company, specializing in comprehensive funeral services across mainland China, Taiwan, Hong Kong, and Vietnam. Its business is divided into two primary divisions: Funeral Services, and Stem Cells, Immunocytes, and Other Business. Within the Funeral Services segment, the company offers arrangement services for both funeral and non-funeral deed holders, alongside cremation services conducted at its various funeral parlours and service centers. Additionally, it manages the sale of burial plots and tombstones, provides cemetery maintenance, and extends elderly care with associated consultancy services. The Stem Cells, Immunocytes, and Other Business division concentrates on delivering advisory services related to stem cells and immunocytes, as well as the distribution of specialized biotechnology equipment. The company was founded in 2005 and maintains its headquarters in Sheung Wan, Hong Kong.

                  Sino-Life Group Limited (8296) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Fu Shou Yuan International Group
                  Anxian Yuan China Holdings Limited
                  China Wan Tong Yuan (Holdings) Ltd.
                  Popular Stocks